Prodromal Alzheimer's Disease
23
6
6
7
Key Insights
Highlights
Success Rate
70% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
13.0%
3 terminated out of 23 trials
70.0%
-16.5% vs benchmark
4%
1 trials in Phase 3/4
43%
3 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (23)
Alzheimer's Tau Platform: Master Protocol
Alzheimer's Tau Platform: Regimen A - AADvac1
Exploring the Gut-Brain Axis in Ageing and Neurodegeneration
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
Financial Incentives and Recruitment to the APT Webstudy
Combined tDCS and Cognitive Training in Alzheimer's
Clinical Trial of AGB101 for Mild Cognitive Impairment
Partnered Rhythmic Rehabilitation in Prodromal Alzheimer's Disease
The Digital Memory Notebook
Deferiprone to Delay Dementia (The 3D Study)
TRC-PAD Program: In-Clinic Trial-Ready Cohort
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension
Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - FUTURE Extension
Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease
Brain Iron Toxicity and Neurodegeneration - A 7T MRI Study
Hyperbaric Oxygen Therapy for Prodromal Alzheimer´s Disease With Cerebrovascular Disease
COGNIFOOD-Changing the Carbohydrate/Fat-ratio to Prevent Cognitive Decline and Alzheimer Pathology: A Pilot Study
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension
Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - PAST Extension
Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech